Keywords: actelion, 1st-qtr, loss, deepens, swiss, biotechnology, firm

Actelion's 1st-qtr 2007 loss deepens 179%

Article | 30 April 2007

Swiss biotechnology firm Actelion says that its first-quarter 2007 net revenue rose to 290.4 million Swiss francs ($394.1 million) from 210.6 million francs in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

bosentan

Tracleer

Iloprost

Ventavis

Miglustat

Go to drug listing